B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiamine.

Palle Bager, Christian Lodberg Hvas, Mette Mejlby Hansen, Per Ueland, Jens Frederik Dahlerup

Journal: Molecular medicine (Cambridge, Mass.) 2023;29(1):143

PMID: 37880581

Plain Language Summary

plain language summary logo

IBD is characterised by chronic inflammation of the gastrointestinal tract with periodic inactive (quiescent disease) and periodic active inflammation. Chronic fatigue is regarded as elevated fatigue levels with duration of more than 6 months. Malnutrition in patients with IBD is well known and this study assessed changes in B-vitamins and their related metabolites directly after high dose oral thiamine, vitamin B1. 40 adult patients with quiescent IBD and chronic fatigue were randomised compared to a control group of 20 patients without fatigue. In total, 52 females and 8 men took part in the trial. Half of the patients had Crohn’s disease and half had ulcerative colitis. Blood samples were taken and patients answered questionnaires regarding fatigue at each study visit. The researchers found low levels of Flavin mononucleotide (FMN), a biomolecule produced from riboflavin (vitamin B2) in patients with chronic fatigue in comparison to patients without fatigue. The researchers also observed that fatigued IBD patients had a less diverse microbiome with reduced numbers of butyrate-producing bacterial species compared to non-fatigued patients, highlighting the importance of vitamin B1 for the growth of gut bacteria. The oral dose of vitamin B1 administered is unclear and other factors influencing fatigue such as diet, sleep and physical activity were not investigated. The researchers conclude the mechanisms of B-vitamins in IBD in relation to fatigue does require further exploration along with assessing vitamin B2’s effect on IBD fatigue.

Expert Review

Reviewer: Chloe Steele
29th Apr 2024
plain language summary logo

Conflict of interest

None

Take home message

  • This was a small secondary analysis of samples and data from a previous RCT and further investigations would be of benefit to confirm findings.
  • However, low plasma B2 vitamin and FMN levels may be associated with chronic fatigue in individuals with IBD.
  • Thiamine supplementation may result in higher use of riboflavin and ways to support these should be considered and may improve outcomes in this patient group.

Evidence category

A: Meta-analyses, position-stands, randomized-controlled trials (RCTs)

Summary review

Introduction

Fatigue is considered a symptom of inflammatory bowel disease (IBD), and may be related to nutrient deficiencies and inflammation. Thiamine is an essential vitamin in the biosynthesis of adenosine triphosphate and energy, however deficiency amongst individuals with IBD is not common and so not monitored. This study aimed to compare plasma B vitamin levels, and their related metabolites and vitamers of individuals with quiescent IBD either with fatigue or without fatigue and determine the effect of high dose thiamine on fatigue.

Methods

  • This was a secondary analysis of blood plasma samples collected from a previous randomised control trial (RCT), which looked at the supplementation of high dose thiamine on levels of fatigue in individuals with IBD.
  • Samples were available from 60 individuals with IBD; 40 individuals with quiescent IBD and chronic fatigue. 20 individuals with quiescent IBD and no fatigue.
  • 21 B vitamins and their associated metabolites and vitamers were analysed.

Results

  • Of the 21 measures, only flavin mononucleotide (FMN), a B2 vitamer, was different between those with IBD and fatigue and those with IBD without fatigue. Those with fatigue had lower median FMN levels than those without (11.1 nmol/L; IQR 8.4 to 13.7 vs 14.2 nmol/l; IQR 10.9 to 17.0; P= 0.02).
  • Thiamine treatment amongst those with fatigue increased thiamine levels, but had no effect on other metabolites or vitamers (statistics not given).
  • Individuals with fatigue who improved with thiamine treatment showed a drop in riboflavin levels after therapy was given (P=0.01), whilst all other B vitamins, vitamers, and metabolites stayed the same.

Conclusion

  • It was concluded that amongst the vitamers, metabolites, and B vitamins analysed, only FMN and riboflavin are associated with chronic fatigue in individuals with IBD.

Clinical practice applications

  • Low FMN may be involved in the development of fatigue in individuals with IBD.
  • This trial did not show if vitamin B2 supplementation would be of benefit to individuals with IBD and chronic fatigue.
  • Lower riboflavin levels following thiamine supplementation may be associated with an increase in its use for thiamine mediated ATP production.
  • This study may be able to inform future research or support the supplementation of B2 if further research is found.
  • Blood plasma levels of other B vitamins and their metabolites and vitamers is unlikely to be related to chronic fatigue in individuals with IBD.
  • Use of the IBD fatigue questionnaire may be of utility in clinical practice.

Considerations for future research

  • Larger RCTs, which have been designed to analyse this specific research question are warranted, as this study was conducted in a small number of individuals as a secondary analysis of samples from another RCT.
  • Supplementation RCTs of vitamin B2 alone and in combination with thiamine on individuals with IBD and chronic fatigue would be of benefit.
plain language summary logo
Expert reviews are written by nutrition professionals and academics with advanced qualifications to provide a critical appraisal of the article and implications for practice. Each review is peer-reviewed by a member of the NED Editorial Board. Find out more about our NED Expert Reviewers here.

Abstract

BACKGROUND

High doses of oral thiamine improve clinical fatigue scores in patients with quiescent inflammatory bowel disease (IBD) and chronic fatigue. In this study we analysed plasma samples obtained in a randomised clinical trial and aimed compare levels of vitamins B1, B2, B3 and B6, and their related vitamers and metabolites in patients with IBD, with or without chronic fatigue and with or without effect of high dose oral thiamine for chronic fatigue.

METHODS

Blood samples from patients with fatigue were drawn prior and after thiamine exposure and only once for patients without fatigue. A wide panel of analysis were done at Bevital AS Lab.

RESULTS

Concentration of flavin mononucleotide (FMN) was lower in patients with chronic fatigue compared to patients without fatigue (p = 0.02). Patients with chronic fatigue who reported a positive effect on fatigue after 4 weeks of high dose thiamine treatment had a statistically significantly lower level of riboflavin after thiamine treatment (p = 0.01).

CONCLUSION

FMN and Riboflavin were associated with chronic fatigue in patients with quiescent IBD. Levels of other B vitamins and metabolites were not significantly different between the investigated groups or related to effect of the thiamine intervention.

CLINICAL TRIAL REGISTRATION

ClinicalTrials.gov study identifier NCT036347359. Registered 15 August 2018, https://clinicaltrials.gov/study/NCT03634735?cond=Inflammatory%20Bowel%20Diseases&intr=Thiamine&rank=1.

© 2023. The Feinstein Institute for Medical Research.

Address: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. [email protected].; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.; Bevital AS, Jonas Lies Veg 87, 5021, Bergen, Norway.

Patient Centred Factor

Physical Environment

Laboratory Testing

Modifiable Lifestyle Factors

Jadad Score

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.